Microbix Biosystems (TSX:MBX) Common Stock : C$49.24 Mil (As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Common Stock?

Microbix Biosystems's quarterly common stock declined from Sep. 2023 (C$49.04 Mil) to Dec. 2023 (C$48.99 Mil) but then increased from Dec. 2023 (C$48.99 Mil) to Mar. 2024 (C$49.24 Mil).

Microbix Biosystems's annual common stock increased from Sep. 2021 (C$43.61 Mil) to Sep. 2022 (C$49.92 Mil) but then declined from Sep. 2022 (C$49.92 Mil) to Sep. 2023 (C$49.04 Mil).

Microbix Biosystems Common Stock Historical Data

The historical data trend for Microbix Biosystems's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Common Stock Chart

Microbix Biosystems Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Common Stock

Get a 7-Day Free Trial

33.91

35.36

43.61

49.92

49.04

Microbix Biosystems Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															49.34	49.10	49.04	48.99	49.24

Microbix Biosystems Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Microbix Biosystems (TSX:MBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

MBXBF:USA

Address

265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3

Website

https://www.microbix.com

Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.

Executives

James Stuart Currie

Senior Officer

Microbix Biosystems (TSX:MBX) Headlines

No Headlines